UBE2A as a prognostic indicator across human cancers: Insights from multi-omics and immune landscape analyses
Yun Wen, Pengfei Luo · 2026
Read UBE2A as a prognostic indicator across human cancers: Insights from multi-omics and immune landscape analyses by Yun Wen, Pengfei Luo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13443290.txt.
Description
Yun Wen and Pengfei Luo size up a cell enzyme, UBE2A, as a cancer mark across tumor types in a 2026 study. The enzyme tags proteins for fate calls inside cells, and its cancer role stayed blurry. Public sets from tumor banks and gene banks fed checks on levels, outlook, gene traits, and immune ties.
UBE2A ran high in many cancer types, and high marks tracked with worse survival odds. Its levels also tracked with immune cell mix and brake gene marks in tumors. Single-cell reads placed the enzyme thick in fast-growing T cells. Bench tests in breast cancer cells showed that silencing UBE2A curbed growth, spread, and invasion. The authors pitch UBE2A as a broad outlook mark with immune links worth drug study.
Catalog record
| CREATOR | Yun Wen, Pengfei Luo |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 50 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |